Role of Fungal Microflora in Mucosal Tolerance/Immunity
Role of Fungal Microflora in Mucosal Tolerance/Immunity
批准号:
7218573
负责人:
Gary B Huffnagle
金额:
$35.79万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31
关键词:
14 year oldAgeAllergensAllergicAnimal ModelAnimalsAntibioticsAntigensAreaAsthmaAustraliaBasic ScienceBreathingCanadaCandidaCenters for Disease Control and Prevention (U.S.)ChildCountryCoupledDataDefectDeglutitionDeveloped CountriesDeveloping CountriesDevelopmentDietDiseaseDisruptionEpidemiologic StudiesEventFoundationsFutureGastrointestinal tract structureGenerationsGeneticGerm-FreeGreat BritainGrowthHumanHygieneHypersensitivityImmune responseImmunityIncidenceInflammatory ResponseIrelandLaboratoriesLifeLungModelingMusNew ZealandNumbersPlayPopulationPredisposing FactorProbioticsRateReportingResearch PersonnelRoleSchool-Age PopulationT-LymphocyteTestingTimeUnited KingdomUnited StatesVirulence Factorsallergic airway diseaseasthmatic patientconceptenvironmental changegastrointestinalmicrobialpreventreconstitutionresponsesugar
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the past 40 years, the rates of asthma and allergies have increased dramatically in westernized countries (>30% of school age children in the US, Great Britain, New Zealand and Australia currently have asthma). The mechanism(s) underlying this increase is unknown. However, this staggering increase in the incidence of asthma in this time frame indicates that factors beyond genetics play a major role in the development of the disease. Numerous epidemiologic studies in humans have shown a correlation between antibiotic use or altered fecal microflora and the development of allergies. The hypothesis of this proposal is that the microflora plays a central role in maintaining mucosal tolerance to inhaled/swallowed antigens, which prevents the development of over-exuberant inflammatory responses to these antigens (i. e. allergies). Thus, changes in microflora populations, including increased growth of fungal microflora (Candida), decrease mucosal tolerance resulting in the development of allergic responses to inhaled allergens. Antibiotics and diet have a major impact on the composition of the microflora. We have generated an animal model to test this hypothesis and our preliminary studies with this model support the concept that altered microflora can be a potential mechanism underlying the development of allergic airway disease. The specific aims of this proposal are the following: 1. To analyze the dynamics of microbiota reconstitution that occurs following the cessation of antibiotics in the presence and absence of Candida in the gastrointestinal tract. 2. To determine the effect of different Candida species and isolates on disrupting mucosal tolerance and to determine the duration of defective mucosal tolerance. 3. To analyze the contribution of Candida "virulence" factors in disrupting mucosal tolerance in mice during Candida persistence in the Gl tract. 4. To determine whether antibiotic-induced microbiota disruption alters the development of antigen-specific regulatory T cell responses for the lungs. These studies will provide the basic science foundation for future studies in humans for understanding how and why manipulation of the microflora (by diet or probiotics) can alter or prevent allergies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:10448373
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:9763430
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Neonatal RSV infection and alteration of allergic immune responses
-
批准号:10219079
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2018
-
负责人:Gary B Huffnagle
-
依托单位:
Functional Analysis of the Pulmonary Microbiome during COPD
-
批准号:9542530
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2017
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8509021
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8337156
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
-
批准号:8669148
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Gary B Huffnagle
-
依托单位:
The Role of the Microbiome in the Development/Prevention of Food Allergies
-
批准号:7873387
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2010
-
负责人:Gary B Huffnagle
-
依托单位:
The Role of the Microbiome in the Development/Prevention of Food Allergies
-
批准号:8141254
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2010
-
负责人:Gary B Huffnagle
-
依托单位:
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis
-
批准号:8026744
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2010
-
负责人:Gary B Huffnagle
-
依托单位:
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity
-
批准号:7898627
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2009
-
负责人:Gary B Huffnagle
-
依托单位:
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity
-
批准号:7701050
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2009
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7392833
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:6907647
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7027625
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Fungal Microflora in Mucosal Tolerance/Immunity
-
批准号:7590336
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2005
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7012755
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7343260
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:7172258
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
Role of Oxylipins in Cryptococcal Pathogenesis
-
批准号:6758954
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2004
-
负责人:Gary B Huffnagle
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: